Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses
Most Cited Paper
in Estrogen and related hormone effects
18 Months Post-Publication
Class of 2026
“Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
menopausal hormone therapy beyond age 65 · Medicare prescription drug and encounter records · Time-dependent Cox proportional hazards regression · Estrogen monotherapy · estrogen-progestogen therapy · estrogen-progestogen therapy · transdermal estrogen · vaginal estrogen · oral estrogen · conjugated equine estrogen · estradiol · all-cause mortality · breast cancer risk · endometrial cancer · colorectal cancer · congestive heart failure (CHF) · venous thromboembolism · Coronary heart disease · dementia risk · dose-response relationship
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Estrogen and related hormone effects Papers, Class of 2026. https://pri.pepkio.com/top-papers/estrogen-and-related-hormone-effects/2026. Accessed 2026-07-31. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459